Teva Investor Suit Over $40.5B Merger Sent To Conn.
A Pennsylvania federal judge on Tuesday transferred to Connecticut two proposed investor class actions against Teva Pharmaceutical Industries Ltd. claiming the company hid the negative fallout from its $40.5 billion acquisition...To view the full article, register now.
Already a subscriber? Click here to view full article